Replies to post #52055 on Cytogenix (fka CYGX)

[Paulness]

Geneva conference is going to be very interesting ,in that Cytogenix is the only one there that has a novel synDNA way of making vaccines ,all the other big boys are using pDNA which is the bacterial grown version . Cytogenix is looking better and better as more tests are conducted and the data is collected showing , scale of production , lower price, effectiveness, and speed of product production , more eyes are being focused now on this new technology , Geneva conference in 50 days should be very exciting for the share holders .